Achilles Therapeutics plc

ACHL · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$70-$71-$61-$33
Dep. & Amort.$5$4$3$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$7$6$3
Change in WC$10-$6-$8$3
Other Non-Cash$0$7-$0$1
Operating Cash Flow-$48-$60-$59-$25
Investing Activities
PP&E Inv.-$1-$8-$8-$12
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$8-$8$0
Investing Cash Flow-$1-$8-$8-$12
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$161$115
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$161$114
Financing Cash Flow$0$0$0$114
Forex Effect$8-$26-$5$4
Net Chg. in Cash-$42-$93$89$80
Supplemental Information
Beg. Cash$173$266$178$98
End Cash$132$173$266$178
Free Cash Flow-$50-$67-$67-$37
Achilles Therapeutics plc (ACHL) Financial Statements & Key Stats | AlphaPilot